Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Keith Campbell

Showing results (11-20 of 52) with videos related to

Pageof 6
Sort By:
Journal of Pharmacy Practice|August 5, 2011
Clinical efficacy of colesevelam in type 2 diabetes mellitusLuigi Brunetti, R Keith Campbell
The Diabetes Educator|September 29, 2009
New therapeutic horizons: mapping the future of glycemic control with incretin-based therapyR Keith Campbell, Sara Miller
The Diabetes Educator|January 16, 2003
Counseling patients with type 2 diabetes and insulin resistance in the outpatient settingR Keith Campbell, John White
The Diabetes Educator|February 21, 2002
Assessing diabetes patients' healthcare needsR Keith Campbell, James A Bennett
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|September 3, 2010
Saxagliptin: a dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes mellitusJoshua J Neumiller, R Keith Campbell
The Diabetes Educator|June 7, 2008
More choices than ever before: emerging therapies for type 2 diabetesR Keith Campbell, John R White
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|June 21, 2003
Insulin in the treatment of type 2 diabetes mellitusJohn R White, R Keith Campbell
The Diabetes Educator|April 2, 2002
Insulin lispro updateJerry D Meece, R Keith Campbell
The Annals of Pharmacotherapy|July 30, 2009
Liraglutide: a once-daily incretin mimetic for the treatment of type 2 diabetes mellitusJoshua J Neumiller, R Keith Campbell
Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)|August 2, 2002
Insulin therapy in type 2 diabetesR Keith Campbell, John R White
Pageof 6

Showing results (11-20 of 52) with videos related to

Sort By:
Pageof 6
Journal of Pharmacy Practice|August 5, 2011
Clinical efficacy of colesevelam in type 2 diabetes mellitusLuigi Brunetti, R Keith Campbell
The Diabetes Educator|September 29, 2009
New therapeutic horizons: mapping the future of glycemic control with incretin-based therapyR Keith Campbell, Sara Miller
The Diabetes Educator|January 16, 2003
Counseling patients with type 2 diabetes and insulin resistance in the outpatient settingR Keith Campbell, John White
The Diabetes Educator|February 21, 2002
Assessing diabetes patients' healthcare needsR Keith Campbell, James A Bennett
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|September 3, 2010
Saxagliptin: a dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes mellitusJoshua J Neumiller, R Keith Campbell
The Diabetes Educator|June 7, 2008
More choices than ever before: emerging therapies for type 2 diabetesR Keith Campbell, John R White
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|June 21, 2003
Insulin in the treatment of type 2 diabetes mellitusJohn R White, R Keith Campbell
The Diabetes Educator|April 2, 2002
Insulin lispro updateJerry D Meece, R Keith Campbell
The Annals of Pharmacotherapy|July 30, 2009
Liraglutide: a once-daily incretin mimetic for the treatment of type 2 diabetes mellitusJoshua J Neumiller, R Keith Campbell
Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)|August 2, 2002
Insulin therapy in type 2 diabetesR Keith Campbell, John R White
Pageof 6